July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Distinct immune cell subsets on the ocular surface of dry eye disease and keratoconus patients is associated with pathology
Author Affiliations & Notes
  • Swaminathan Sethu
    GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India
  • Archana Padmanabhan Nair
    GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India
  • sharon dsouza
    Cornea and Refractive Surgery, Narayana Nethralaya Post Graduate Institute of Ophthalmology, Bangalore, India
  • Rohit S
    Cornea and Refractive Surgery, Narayana Nethralaya Post Graduate Institute of Ophthalmology, Bangalore, India
  • Arkasubhra Ghosh
    GROW Research Lab, Narayana Nethralaya Foundation, Bangalore, India
  • Footnotes
    Commercial Relationships   Swaminathan Sethu, None; Archana Nair, None; sharon dsouza, None; Rohit S, None; Arkasubhra Ghosh, None
  • Footnotes
    Support  Narayana Nethralaya Foundation, Bangalore, India (seed grant)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 4734. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Swaminathan Sethu, Archana Padmanabhan Nair, sharon dsouza, Rohit S, Arkasubhra Ghosh; Distinct immune cell subsets on the ocular surface of dry eye disease and keratoconus patients is associated with pathology. Invest. Ophthalmol. Vis. Sci. 2019;60(9):4734.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Ocular surface (OS) conditions such as dry eye (DE) and Keratoconus(KC) are known to be immune-mediated. However, the relationship of trafficking immune cell types with these conditions in humans is underexplored. Hence, we studied the immune cell subsets on the OS of these patients.

Methods : OS immune cells were collected using sterile saline from healthy control subjects (Ctrls, 37 eyes), evaporative DE (EDE, 16 eyes), aqueous-deficient DE (ADE, 16 eyes), ADE- Stevens-Johnson syndrome (ADE-SJS, 20 eyes) and KC (61 eyes) patients with prior informed consent and ethics committee approval. Patients underwent vision testing, Schirmers test I (ST), TBUT, OSDI scoring and corneal topography imaging. OS immune cells collected were stained with antibodies for leukocytes(CD45), T cells(CD3), neutrophils(CD66b), macrophages(CD163), Natural Killer cells(CD56), NKT cells(CD3+ CD56+) gamma delta T cells(gdT), and analysed by flow cytometry.

Results : CD45+ cells were significantly (*P<0.05) higher in ADE/ADE-SJS compared to EDE, KC and Ctrls. Significantly higher CD66b+(Total/Hi) was observed in ADE/ADE-SJS and EDE but not in KC compared to Ctrls, and were significantly lower in EDE and KC compared ADE-SJS. Significantly higher CD163+ was observed in ADE. CD56+(Total/Low/Hi) cells were lower in ADE/ADE-SJS, EDE and KC. CD56+ levels were significantly lower than ADE/ADE-SJS compared to KC. Significantly higher levels of gdT cells was observed in ADE-SJS and advanced grade of KC (3/4) compared to Ctrls. CD56+ cells correlated inversely with OSDI(*r= -0.574), and positively with TBUT(*r=0.442) and ST(*r=0.295). CD66b+ cells correlated directly to OSDI(*r =0.554) but inversely to TBUT(*r=-0.517) and ST(*r=-0.682). CD45+ and gdT cells inversely correlated with ST(*r=-0.445 and *r=-0.271, respectively). Significantly higher levels of CD3+, gdT cells and NKT cells, and lower levels of CD56+low and CD56+hi cells were observed in higher grades of KC(≥2) compared to Ctrls. Significantly lower levels of CD66b+low cells were observed in all grades of KC.

Conclusions : Increased activated neutrophils, gdT cells and decreased NK cells are associated with DE types and severity. Lower quiescent neutrophils and NK cells but higher gdT and NKTs were associated with KC severity. Thus, suggesting the role of distinct immune cells in OS disease pathobiology.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×